Mallinckrodt Pharmaceuticals’ drug becomes the first to snag FDA’s approval for hepatorenal syndrome (HRS)
Terlivaz, Mallinckrodt Pharmaceuticals’ drug for HRS, has received FDA approval, making it the first and only drug to be approved in the US for this disease.